Debt to EBITDA ratio Analysis of Relay Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of RLAY
Dec-23-0.0155Very Poor Debt to EBITDA | Dec-22-0.0150Very Poor Debt to EBITDA | Growth-3.17% |
Debt to EBITDA Analysis of Relay Therapeutics Inc
| Debt to EBITDA Ratio of RLAY has fallen by -3.17 % Compared to previous Financial Year. |
| Debt to EBITDA Ratio with value of -0.0000 was highest in Year Dec-20 in last Five Years. |
| Debt to EBITDA Ratio of RLAY trending down for at least three Years. |
| Latest Debt to EBITDA Ratio with value of -0.0155 is lower than Average Debt to EBITDA of -0.0106 in last five years. |
Other Debt to EBITDA Related Info of RLAY that may interest you.
Relay Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| RLAY | 6.41 | 6.3 | 1.75 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of Relay Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.0155 | -0.0150 | -0.0051 | -0.0000 | -0.0172 | -0.0038 |
| Change | -3.17 % | -192.66 % | -16357.86 % | 99.82 % | -351.56 % |
FY Chart of Debt to EBITDA of Relay Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)